Key result
Central PCO2 linearly increases peripheral chemoreflex sensitivity to hypoxia in ~75% of participants.
Why the study?
How central and peripheral chemoreceptor drives to breathe interact in humans remains contentious.
The interaction between central and peripheral chemoreceptor drives to breathe in humans is additive, as peripheral chemoreflex sensitivity to hypoxia increases linearly with central PCO2.
Refines ventilatory control models in humans; leaves open clinical translation to hypoxia or disease states.
How central and peripheral chemoreceptor drives to breathe interact in humans remains contentious. We measured the peripheral chemoreflex sensitivity to hypoxia (PChS) at various isocapnic CO 2 tensions () to determine the form of the relationship between PChS and central . Twenty participants (10F) completed three repetitions of modified rebreathing tests with end‐tidal () clamped at 150, 70, 60 and 45 mmHg. End‐tidal (), , ventilation ( E ) and calculated oxygen saturation (S C O 2 ) were measured breath‐by‐breath by gas‐analyser and pneumotach. The E – relationship of repeat‐trials were linear‐interpolated, combined, averaged into 1 mmHg bins, and fitted with a double‐linear function ( E S, L min −1 mmHg −1 ). PChS was computed at intervals of 1 mmHg of as follows: the difference in E between the three hypoxic profiles and the hyperoxic profile (∆ E ) was calculated; three ∆ E values were plotted against corresponding S C O 2 ; and linear regression determined PChS (Lmin −1 mmHg −1 %S C O 2 −1 ). These processing steps were repeated at each to produce the PChS vs . isocapnic relationship. These were fitted with linear and polynomial functions, and Akaike information criterion identified the best‐fit model. One‐way repeated measures analysis of variance assessed between‐condition differences. E S increased ( P < 0.0001) with isoxic from 3.7 ± 1.5 L min −1 mmHg −1 at 150 mmHg to 4.4 ± 1.8, 5.0 ± 1.6 and 6.0 ± 2.2 Lmin −1 mmHg −1 at 70, 60 and 45 mmHg, respectively. Mean S C O 2 fell progressively (99.3 ± 0%, 93.7 ± 0.1%, 90.4 ± 0.1% and 80.5 ± 0.1%; P < 0.0001). In all individuals, PChS increased with , and this relationship was best described by a linear model in 75%. Despite increasing central chemoreflex activation, PChS increased linearly with indicative of an additive central–peripheral chemoreflex response. image Key points How central and peripheral chemoreceptor drives to breathe interact in humans remains contentious. We measured peripheral chemoreflex sensitivity to hypoxia (PChS) at various isocapnic carbon dioxide tensions () to determine the form of the relationship between PChS and central . Participants performed three repetitions of modified rebreathing with end‐tidal fixed at 150, 70, 60 and 45 mmHg. PChS was computed at intervals of 1 mmHg of end‐tidal () as follows: the difference in E between the three hypoxic profiles and the hyperoxic profile (∆ E ) was calculated; three ∆ E values were plotted against corresponding calculated oxygen saturation (S C O 2 ); and linear regression determined PChS (Lmin −1 mmHg −1 %S C O 2 −1 ). In all individuals, PChS increased with , and this relationship was best described by a linear (rather than polynomial) model in 15 of 20. Most participants did not exhibit a hypo‐ or hyper‐additive effect of central chemoreceptors on the peripheral chemoreflex indicating that the interaction was additive.
No takes yet. Share an insight, caveat, or question.
Guluzade et al. (2023) studied this question. Hypoxia at various isocapnic CO2 tensions vs. Hyperoxia (150 mmHg) was evaluated on Peripheral chemoreflex sensitivity to hypoxia (PChS) (p=<0.0001). Peripheral chemoreflex sensitivity to hypoxia increased linearly with central PCO2 in 75% of participants, indicating an additive central-peripheral chemoreflex response.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: